Showing results (291-300 of 2,355) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|May 8, 2012
Combined beneficial effect of rasagiline on motor function and depression in de novo PDAlexei Korchounov, Yaroslav Winter, Wolfgang RössyClinical Neuropharmacology|May 8, 2012
Atomoxetine once daily for 24 weeks in adults with attention-deficit/hyperactivity disorder (ADHD): impact of treatment on family functioningLinda Wietecha, Joel Young, Dustin Ruff, et al.Clinical Neuropharmacology|December 14, 2011
Pregabalin beneficial effects on sleep quality or health-related quality of life are poorly correlated with reduction on pain intensity after an 8-week treatment courseSantiago Perez-Lloret, Gloria Meza Rojas, Maria Celia Menoni, et al.Clinical Neuropharmacology|November 19, 2011
Pharmacotherapeutic implications of the association between genomic instability at chromosome 15q13.3 and autism spectrum disordersStephen I Deutsch, Maria R Urbano, Jessica A Burket, et al.Clinical Neuropharmacology|August 1, 1990
Immunoreactive beta-endorphin, cortisol, and growth hormone plasma levels in obsessive-compulsive disorderR Weizman, I Gil-Ad, H Hermesh, et al.Clinical Neuropharmacology|August 1, 1990
Apomorphine in the diagnosis and treatment of parkinsonian tremorA J Hughes, A J Lees, G M SternClinical Neuropharmacology|August 1, 1990
Failure of fixed-dose, fixed muscle injection of botulinum toxin in torticollisW Koller, B Vetere-Overfield, C Gray, et al.Clinical Neuropharmacology|June 6, 2012
A randomized, double-blind, placebo-controlled, dose-response study to assess the pharmacokinetics, efficacy, and safety of gabapentin enacarbil in subjects with restless legs syndromeRitu Lal, Aaron Ellenbogen, Dan Chen, et al.Clinical Neuropharmacology|July 20, 2011
Is circadian rhythm disruption important in obsessive-compulsive disorder (OCD)? A case of successful augmentation with agomelatine for the treatment of OCDFelipe Filardi da Rocha, Humberto CorreaClinical Neuropharmacology|October 15, 2011
Efficacy of parecoxib, sumatriptan, and rizatriptan in the treatment of acute migraine attacksThomas Müller, Lutz LohsePageof 236